Abstract
Fasting, which is important in many ancient religions, is also one of the basic conditions of Islam. During the month of Ramadan, Muslims do not eat and drink from dawn to sunset. The month of Ramadan continues for 29-30 days and the fasting period ranges from 10 to 20 hours depending on geographic location. The condition for fasting is to be healthy and not have chronic illness. However, with the thought that it is a religious obligation and will provide spiritual benefit, most individuals with chronic diseases also want to fast. Diabetes mellitus (DM) is considered a high risk condition for fasting in Ramadan, as it is a chronic metabolic disease and carries risks such as hypoglycemia and hyperglycemia during fasting. Hypoglycemia is a common problem during fasting during Ramadan. However, in clinical practice, most individuals with DM prefer to fast. Therefore, healthcare professionals must provide training to protect individuals with DM against various risks and to prevent hypoglycemic and hyperglycemic events. This review has been prepared in order for health professionals to make recommendations such as dose adjustment, risk classification, education, pharmacotherapy and blood glucose monitoring, medication and in line with the recommendations of the guidelines for type 1 and type 2 DM adults who plan to fast during Ramadan.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
